Cardiovascular disease Trials in Columbus, United States
Conditions / Cardiovascular disease / Columbus, United States
Cardiovascular disease has been the subject of sustained clinical investigation across multiple research sites.
25 total trials for this combination
Showing top 10 of 25 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01394952 | Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) | COMPLETED | PHASE3 |
| NCT00327691 | A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels | COMPLETED | PHASE4 |
| NCT01975376 | The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects | TERMINATED | PHASE3 |
| NCT01594333 | Cardiovascular Inflammation Reduction Trial | COMPLETED | PHASE3 |
| NCT01609582 | Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease | TERMINATED | PHASE3 |
| NCT05284747 | EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction | ACTIVE_NOT_RECRUITING | PHASE4 |
| NCT07000357 | A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event | RECRUITING | — |
| NCT02499731 | Strong Hearts: Rural CVD Prevention | COMPLETED | NA |
| NCT01975389 | The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects | TERMINATED | PHASE3 |
| NCT01031680 | Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension | COMPLETED | PHASE3 |